Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Why this KC social entrepreneur pivoted from drilling wells with Matt Damon to tapping micro-loans for water projects
Identifying unmet needs is just as critical for social entrepreneurs as their counterparts at more traditional for-profit ventures, said Gary White, explaining how Water.org needed to find its missing piece to truly tap the non-profit’s potential. “Go after those unique insights at the intersection of a great social gain and a market,” said White, offering…
Newly relaunched PR platform connects small brands to freelance journalists eager to tell their stories
Blish Mize Connor and Allison Hogan are working to change the landscape of the public relations game, they shared, starting with firing themselves. The PR veterans — with a combined 35 years of experience — have launched DeskSides, a dual-sided digital hub to connect brands with journalists/freelancers. “We were tired of traveling and schlepping goods…
US company lands on the moon: Here’s how a KC firm helped boost its flames of innovation
For the first time ever, a commercial spacecraft has touched down on the moon and Kansas City-based Burns & McDonnell provided innovation that helped to make it possible for Intuitive Machines and its Odysseus IM-1 lander, shared Brittney Swartz. The local engineering, construction and architecture firm served as the designer and builder of Intuitive Machines’…
Why developers say folding Plexpod Westport site into Park 39 unifies $230M project
A move this week to transition management of the Plexpod Westport space to the developers behind a massive project along 39th Street will mean reuniting elements within the broader Park 39 campus, said Andrew Brain. “By unifying our actions on both sides of the street, we’re able to act as a whole instead of as…